Kaleido BioSciences

About:

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

Website: http://www.kaleido.com

Twitter/X: kaleidobio

Top Investors: Fidelity, Invus, Abu Dhabi Investment Authority, Rock Springs Capital, Flagship Pioneering

Description:

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health. The Company has built a human-centric proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.